All News Releases
- Nanosphere to Report 3rd Quarter Results & Hold Investor Conference Call on Thursday, December 13, 2007
- Nanosphere Announces Exercise of Over-Allotment Option and Closing of Initial Public Offering
- Nanosphere Announces Initial Public Offering
- Nanosphere Announces FDA Clearance of Second Molecular Diagnostics Assay
- Nanosphere Announces First FDA Cleared Genetic Test for Warfarin
- Nanosphere Awarded U.S. Patent for Nanoparticle Imaging System and Method
- Nanosphere, Inc. Closes $57 Million Financing
- Applied NeuroSolutions and Nanosphere Sign Research Agreement
- Nanosphere, Inc. Awarded U.S. Patent for Biobarcode Ultra-sensitive Protein Detection Technology
- Nanosphere Appoints Chief Marketing Officer
- Nanosphere Patent Portfolio Ranked Second Strongest in Micro and Nanotech
- Nanosphere Appoints Gregory Shipp, M.D. Vice President of Medical Affairs